Low Woon-Kai, Dang Yongjun, Schneider-Poetsch Tilman, Shi Zonggao, Choi Nam Song, Merrick William C, Romo Daniel, Liu Jun O
Department of Pharmacology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA.
Mol Cell. 2005 Dec 9;20(5):709-22. doi: 10.1016/j.molcel.2005.10.008.
Translation initiation in eukaryotes is accomplished through the coordinated and orderly action of a large number of proteins, including the eIF4 initiation factors. Herein, we report that pateamine A (PatA), a potent antiproliferative and proapoptotic marine natural product, inhibits cap-dependent eukaryotic translation initiation. PatA bound to and enhanced the intrinsic enzymatic activities of eIF4A, yet it inhibited eIF4A-eIF4G association and promoted the formation of a stable ternary complex between eIF4A and eIF4B. These changes in eIF4A affinity for its partner proteins upon binding to PatA caused the stalling of initiation complexes on mRNA in vitro and induced stress granule formation in vivo. These results suggest that PatA will be a valuable molecular probe for future studies of eukaryotic translation initiation and may serve as a lead compound for the development of anticancer agents.
真核生物中的翻译起始是通过大量蛋白质的协同有序作用来完成的,其中包括eIF4起始因子。在此,我们报告,强效抗增殖和促凋亡海洋天然产物帕台胺A(PatA)可抑制帽依赖性真核生物翻译起始。PatA与eIF4A结合并增强其内在酶活性,但它抑制eIF4A与eIF4G的结合,并促进eIF4A与eIF4B之间稳定三元复合物的形成。PatA与eIF4A结合后,其对伴侣蛋白亲和力的这些变化导致体外起始复合物在mRNA上停滞,并在体内诱导应激颗粒形成。这些结果表明,PatA将成为未来真核生物翻译起始研究的有价值分子探针,并可能作为抗癌药物开发的先导化合物。